论文部分内容阅读
目的:观察降钙素原在慢性阻塞性肺疾病急性加重期的应用价值。方法:将2013年1月-2014年6月在英德市人民医院住院治疗的42例慢性阻塞性肺疾病急性加重期患者分为观察组和对照组,均为21例,对比治疗效果。结果:两组患者抗生素应用、二重感染、平均住院时间、平均抗生素使用时间和平均住院费用相比,差异具有统计学意义(P<0.05)。结论:降钙素原可规范抗生素使用,判定慢性阻塞性肺疾病急性加重期患者的病情,缩短患者使用抗菌药物时间。
Objective: To observe the value of procalcitonin in acute exacerbation of chronic obstructive pulmonary disease. Methods: Forty-two patients with acute exacerbation of chronic obstructive pulmonary disease hospitalized in Yingde People’s Hospital from January 2013 to June 2014 were divided into observation group and control group, both of them were 21 cases, and the therapeutic effect was compared. Results: There were significant differences in antibiotic application, double infection, average length of hospital stay, average antibiotic use time and average hospitalization expense between the two groups (P <0.05). Conclusion: The procalcitonin can regulate the use of antibiotics to determine the condition of patients with acute exacerbation of chronic obstructive pulmonary disease and shorten the time of using antibacterials.